BIO Financial Facts

Weighted average common shares - basic: 28.88M
Cost of goods sold: 242.07M
See Full Income Statement

Retained earnings: 1.66B
Total current assets: 1.76B
See Full Balance Sheet

Bio-Rad Laboratories, Inc. (BIO) Earnings

  |   Expand Research on BIO
Next EPS Date 2/27/15 *Est. EPS Growth Rate +260.0% *Last Qtr.
Average EPS % Beat Rate -25.9% Revenue Growth Rate +5.1% *Last Qtr.
Average % Move 1-Wk after EPS +0.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/4/14 Q314 $0.40$0.86 -$0.46$530.6M$525.4M N/A Details
8/5/14 Q214 $1.09$0.95 +$0.14$536.8M$537.58M N/A Details
5/6/14 Q114 $0.23$0.80 -$0.57$509M$515M N/A Details
2/27/14 Q413 $1.51$1.42 +$0.09$602.6M$586.67M N/A Details
11/7/13 Q313 -$0.25$0.91 -$1.16$505.07M$529.02M N/A Details
8/6/13 Q213 $1.20$1.25 -$0.05$525.3M$532.6M N/A Details
5/7/13 Q113 $0.68$1.06 -$0.38$499.7M$506.34M N/A Details
2/26/13 Q412 $1.65$1.34 +$0.31$573.8M$558.68M N/A Details